Preoperative evaluation of hyperparathyroidism: The role of dual-phase parathyroid scintigraphy and ultrasound imaging

Annals of Nuclear Medicine

Volumn 22, Issue 2, 2008, Pages 123-131

  Sukan, Aysun ^a   Reyhan, Mehmet ^a   Aydin, Mehmet ^a   Yapar, Ali F ^a   Sert, Yasar ^b   Canpolat, Tuba ^a   Aktas, Ayse ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

99mTc MIBI; Hyperparathyroidism; Thyroid nodules; Ultrasound

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID SCINTISCANNING; PREOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID DISEASE; ULTRASOUND;

ADENOMA; ADOLESCENT; ADULT; AGED; CALCIUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPLASIA; MALE; MIDDLE AGED; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PHOSPHATES; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ULTRASONOGRAPHY;

EID: 40149105998     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0086-z     Document Type: Article

References (53)

1. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863-1875.
2. John T. Potts. Disease of the parathyroid gland and other hyper and hypocalcemic disorders. In: Harrison's Principles of Internal Medicine, Braunwald E, Fauci AS, Kasper DL (eds), 15th ed. New York: McGrawhill; 2001. p. 2205-2226.
3. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins RE. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
4. Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992;112:1111-1116; discussion 1116-7.
5. Pattou F, Oudar C, Huglo D, Racadot A, Carnaille B, Proye C, et al. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine. J Surg 1998;68:108-111.
6. Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99m Tc-MIBI, (201) Tl, MRI and US. Eur J Nucl Med 2001;28:1817-1827.
7. Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993;20:20-25.
8. Mitchell BK, Cornelius EA, Zoghbi S, Murren JR, Ghoussoub R, Flynn SD. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 1996;120:1039-1045.
9. Neumann DR, Esselstyn CB Jr, Madera AM. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997;169:1671-1674.
10. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH Jr, Coogan AC, Leight GS Jr. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands. Am J Roentgenol 1996;67:1555-1562.
11. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-1807.
12. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy. Am J Med 2000;108:733-736.
13. Kaczirek K, Prager G, Kienast O, Dobrozemsky G, Dudczak R, Niederle B, et al. Combined transmission and (99m) Tcsestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin 2003;42:220-223.
14. Ishibashi M, Uchida M, Nishida H, Hiromatsu Y, Kohno K, Okuda S, et al. Presurgical localization of ectopic parathyroid glands using three-dimensional CT imaging, 99Tcm sestamibi, and 99Tcm tetrofosmin imaging. Br J Radiol 1999;72:296-300.
15. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m MIBI, technetium-99m tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998;39:320-324.
16. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005;35:266-276.
17. Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 2000;35:426-430.
18. Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci C, et al. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. Am J Roentgenol 1996;166:1465-1470.
19. Mazzeo S, Caramella D, Marcocci C, Lonzi S, Cambi L, Miccoli P, et al. Contrast-enhanced color Doppler ultrasonography in suspected parathyroid lesions. Acta Radiol 2000;41:412-416.
20. Norman J, Cheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1003.
21. Wells SA Jr, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM. Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 1976;295:57-62.
22. Rosai and Ackerman's; Ackerman's Surgical Pathology, Juan Rosai, Lauren V. Ackerman. 9th ed. Parathyroid glands. 9th ed. Philadelphia: Mosby; 2004. p. 597-601.
23. Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28:209-213.
24. Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998;39:1441-1444.
25. Hajioff D, Iyngkaran T, Panagamuwa C, Hill D, Stearns MP. Preoperative localization of parathyroid adenoma: ultrasonography, sestamibi scintigraphy, or both? Clin Otolaryngology 2004:29:549-552.
26. Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004;28:100-107.
27. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands. Clin Endocrinol (Oxf) 2002;57:241-249.
28. Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon, Hubalewska A, et al. Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas in directing surgical approach. Clin Endocrinol (Oxf) 2006;65:106-113.
29. Mortier P-E, Mozzon MM, Fouquet OP, Soudan BC, Huglo DG, Cussac JF. Unilateral Surgery for Hyperparathyroidism: Indications, Limits, and Late Results-New Philosophy or Expensive Selection without Improvement of Surgical Results? World J Surg 2004;28:1298-1304.
30. Ambrosoni P, Heuguerot C, Olaizola I, Acuna G, Fajardo L, Petraglia A, et al. Can we use 99mTc-MIBI in functional studies of the parathyroid gland? Nephrol Dial Transplant 1998;13Suppl 3:33-36.
31. Hung GU, Wang SJ, Lin WY. Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 2003;28:180-185.
32. Biertho LP, Kim C, Wu HS, Ungar P, Inabnet WB. Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 2004;199:229-233.
33. Feinfeld DA, Sherwood LM. Parathyroid hormone and 1,25(OH) 2D3 in chronic renal failure. Kidney Int 1988;33:1049-1058.
34. Sekiyama K, Akakura K, Mikami K, Mizoguchi K, Tobe T, Nakano K, et al. Usefulness of diagnostic imaging in primary hyperparathyroidism. Int J Urol 2003;10:7-11; discussion 12.
35. Moka D, Eschner W, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas? Eur J Nucl Med 2000;27:485-489.
36. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: Combination of (99m) Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000;214:393-402.
37. Torregrosa JV, Fernandez-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, et al. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000;24:1386-1390.
38. Purcell GP, Dirbas FM, Jeffrey RB, Lane MJ, Desser T, McDougall IR, et al. Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. Arch Surg 1999;134:824-828; discussion 828-30.
39. Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143:755-760.
40. Prager G, Czerny C, Ofluoglu S, Kurtaran A, Passler C, Karzirek K, et al. Impact of localisation studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 2003;196:541-548.
41. Rutledge R, Stiegel M, Thomas CG Jr, Wild RE. The relation of serum calcium and intact parathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 1985;98:1107-1112.
42. Saxe AW, Lincenberg S, Hamburger SW. Can the volume of abnormal parathyroid tissue is predicted by preoperative biochemical measurement? Surgery 1987;102:840-845.
43. Adalet I, Hawkins T, Clark F, Wilkonson R. 1994 Thallium-technetium- subtraction scintigraphy in secondary hyperparathyroidism. Eur J Nucl Med 1994;21:509-513.
44. Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparao thyroidism. J Nucl Med 1996;37:565-569.
45. Ryan JA, Eisemberg B, Pado KM and Lee. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997;132:886-890.
46. Taira N, Doihara H, Hara F, Shien T, Takabatake D, Takahashi H, et al. Less invasive surgery for primary hyperparathyroidism based on preoperative 99mTc-hexakis-2-methoxyisobutylisonitrile imaging fi ndings. Surg Today 2004;34:197-203.
47. Regal M, Paramo C, Luna Cano R, Perez Mendez LF, Sierra JM, Rodriguez I, et al. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest 1999;22:191-197.
48. dell'Erba L, Baldari S, Borsato N, Bruno G, Calo-Gabrieli G, Carletto M, et al. Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism. Eur J Endocrinol 2001;145:429-434.
49. Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997;21:287-290; discussion 290-1.
50. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997;24:143-149.
51. Masatsugu T, Yamashita H, Noguchi S, Nishii R, Watanabe S, Uchino S, et al. Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease. Surg Today 2005;35:351-356.
52. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904-908.
53. Nishiyama RH, Farhi D, Thompson NW. Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules. Surg Clin North Am 1979;59:65-75.